Welcome to VnrWiki

27.9.2016 

From NTIN to GTIN –a new section in VnrWiki
The coding of medicines changes because of the requirements of the Falsified Medicines directive. Pharma companies have to make sure that the product codes are unique (GTIN or unique NTIN).
The codes are extremely important, because all information used in different IT-systems in health care, pharmacies, wholesalers, robots etc. are based on codes that link to the correct information to be shown for users.
To help and support pharma companies we have prepared guidance about GTINs in pharmaceuticals. The guidance has been produced together with Nordic Vnr co-operation group and GS1. The guidance documents are now published here in VnrWiki in the new section “From NTIN to GTIN

New rules governing medicine packages in Denmark
The Danish Medicines Agency has issued a new guideline on variations to marketing authorizations for medicinal products and a new executive order on product numbers for medicinal products.
With the new guideline, the Danish Medicines Agency will ease the administrative and financial burden of implementing certain administrative variations. For example, if the MA changes ownership or other changes are made to the company information.
Note that the product number requirement is also eased for multi packages and large packages
(see Changes in Vnr information, Country specific information Denmark)

This webpage contains information and guidelines regarding Vnr numbers. Vnr administration is located at vnr.fi.

Browse the common Nordic guidelines pages using the page navigation on the right. These may always be browsed throughout the wiki.

Country specific information can be accessed via guideline pages, where applicable, or the full text can be viewed from the top menu panel under each Nordic country.

In addition, the site contains annual Vnr statistics in a printable form.

**********************************************************

The Guideline on Nordic Packages document contains general information on Nordic packages, whereas the Frequently Asked Questions document gives detailed advice on different package issues. The documents are a product of cooperation between the Medicines Agencies in Denmark, Finland, Iceland, Norway and Sweden.

Guideline on Nordic packages (pdf pdf)
Frequently asked questions (pdf pdf)